OTCMKTS:ECTE

Echo Therapeutics (ECTE) Stock Price, News & Analysis

$0.0002
0.00 (0.00%)
(As of 09/7/2021)
Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
$0.28
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ECTE stock logo

About Echo Therapeutics Stock (OTCMKTS:ECTE)

Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.

ECTE Stock Price History

ECTE Stock News Headlines

What are echo chambers?
ECTE/USD Synthetic Historical Data
What is Medicare Supplement Insurance?
Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you.
ECTE Historical Data
It’s now possible to know the win rate of every trade… BEFORE you take it!
Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
Echo Therapeutics Inc.
See More Headlines
Receive ECTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Echo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/12/2016
Today
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:ECTE
Previous Symbol
NASDAQ:ECTE
Employees
17
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

ECTE Stock Analysis - Frequently Asked Questions

How have ECTE shares performed in 2024?

Echo Therapeutics' stock was trading at $0.0002 on January 1st, 2024. Since then, ECTE shares have increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here
.

How were Echo Therapeutics' earnings last quarter?

Echo Therapeutics, Inc. (OTCMKTS:ECTE) announced its quarterly earnings data on Friday, August, 12th. The medical device company reported ($0.82) earnings per share for the quarter. During the same period last year, the firm posted ($0.97) EPS.

What other stocks do shareholders of Echo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Echo Therapeutics investors own include Biocept (BIOC), DexCom (DXCM), Rexahn Pharmaceuticals (REXN), Acer Therapeutics (ACER), Athersys (ATHX), LadRx (CYTR), Glu Mobile (GLUU), InterCloud Systems (ICLD), NetApp (NTAP) and

How do I buy shares of Echo Therapeutics?

Shares of ECTE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ECTE) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners